Inflammasome Priming in Sterile Inflammatory Disease
Abstract
The inflammasome is a cytoplasmic protein complex that processes interleukins (IL)-1β and IL-18, and drives a form of cell death known as pyroptosis. Oligomerization of this complex is actually the second step of activation, and a priming step must occur first. This involves transcriptional upregulation of pro-IL-1β, inflammasome sensor NLRP3, or the non-canonical inflammasome sensor caspase-11. An additional aspect of priming is the post-translational modification of particular inflammasome constituents. Priming is typically accomplished in vitro using a microbial Toll-like receptor (TLR) ligand. However, it is now clear that inflammasomes are activated during the progression of sterile inflammatory diseases such as atherosclerosis, metabolic disease, and neuroinflammatory disorders. Therefore, it is time to consider the endogenous factors and mechanisms that may prime the inflammasome in these conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NLRP3 inflammasome activation is a two-hit process in which signal 1 primes transcription and signal 2 activates the inflammasome and induces secretion of IL-1β and IL-18.
“The functional regulation of an active NLRP3 inflammasome in a cell is a ‘two-hit’ process, in which signal 1 primes the transcription of the inflammasome and signal 2, either by the same and/or additional stimuli, activates the inflammasome and induces secretion of two pro-inflammatory cytokines, IL-1β and IL-18 (REFS63,64).”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 370 · see citing works
RetractedUCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238 · see citing works
RetractedA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · see citing works
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · see citing works
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · see citing works
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · see citing works
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · see citing works
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · see citing works
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,006 · see citing works
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · see citing works
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · see citing works
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N., Bull, H., Calaycay, J., Chapman, K., Howard, A., Kostura, M., Miller, D. K., Molineaux, S., Weidner, J., Auniņš, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,725 · see citing works
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · see citing works
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655 · see citing works
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · see citing works
Inflammatory caspases are innate immune receptors for intracellular LPS
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., & Shao, F. (2014) · Nature · doi:10.1038/nature13683 · Cited by 2,285 · see citing works
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · see citing works
Self-citationNLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature reviews. Immunology · doi:10.1038/nri2725 · Cited by 1,859 · see citing works
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y. L., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P. ‐. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,811 · see citing works
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · see citing works
Immunometabolism governs dendritic cell and macrophage function
O'Neill, L. A. J., & Pearce, E. J. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,715 · see citing works
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618 · see citing works
Lampropoulou, V., Sergushichev, A., Bambousková, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes‐Barragán, L., Ma, X., Huang, S. C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,547 · see citing works
Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
Kayagaki, N., Wong, M. T., Stowe, I. B., Ramani, S. R., Gonzalez, L. C., Akashi‐Takamura, S., Miyake, K., Zhang, J., Lee, W. P., Muszyński, A., et al. (2013) · Science · doi:10.1126/science.1240248 · Cited by 1,545 · see citing works
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 7× · see citing works
“Oxidized LDL is shown to provide both signal 1 and signal 2 to prime and activate NLRP3 inflammasome in mouse models of atherosclerosis [52] and islet amyloid polypeptide (IAPP)-induced inflammasome activation in type 2 diabetes (T2D) ([31]).”
InfluentialSelf-citationCytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., & Miao, E. A. (2013) · Science · doi:10.1126/science.1240988 · Cited by 1,261 · see citing works
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,028 · see citing works
Sensing and reacting to microbes through the inflammasomes
Franchi, L., Muñoz-Planillo, R., & Núñez, G. (2012) · Nature Immunology · doi:10.1038/ni.2231 · Cited by 1,013 · see citing works
Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/s0092-8674(05)80095-9 · Cited by 968 · see citing works
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., Sadler, J. J., Knepper-Adrian, V., Han, R., Qiao, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.001 · Cited by 939 · see citing works
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935 · see citing works
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. Μ., Tenzer, S., Neurath, M. F., et al. (2011) · Nature · doi:10.1038/nature10400 · Cited by 882 · see citing works
NLRP3 inflammasome and its inhibitors: a review
Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00262 · Cited by 836 · cited 1× · see citing works
“There are many excellent recent reviews highlighting the discovery and novel mechanistic understanding of small-molecule inhibitors for NLRs and caspases, and the preclinical/ clinical impact of targeting the inflammasome products IL-1β and IL-18 in disease [138, 139, 140, 141, 142] .”
Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Juliana, C. A., Fernandes‐Alnemri, T., Kang, S., Farias, A., Qin, F., & Alnemri, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407130 · Cited by 771 · see citing works
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E. (2012) · Diabetes · doi:10.2337/db12-0420 · Cited by 730 · see citing works
TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria
Rathinam, V. A. K., Vanaja, S. K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L. M., Leong, J. M., & Fitzgerald, K. A. (2012) · Cell · doi:10.1016/j.cell.2012.07.007 · Cited by 729 · see citing works
Inflammasome is a central player in the induction of obesity and insulin resistance
Stienstra, R., van Diepen, J. A., Tack, C. J., Zaki, M. H., van de Veerdonk, F. L., Perera, D., Neale, G. A., Hooiveld, G. J., Hijmans, A., Vroegrijk, I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100255108 · Cited by 727 · see citing works
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Py, B. F., Kim, M.-S., Vakifahmetoglu-Norberg, H., & Yuan, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.009 · Cited by 718 · see citing works
Jager, J., Grémeaux, T., Cormont, M., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2006) · Endocrinology · doi:10.1210/en.2006-0692 · Cited by 697 · see citing works
Adipokines Mediate Inflammation and Insulin Resistance
Kwon, H., & Pessin, J. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00071 · Cited by 695 · see citing works
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Iyer, S. S., Pulskens, W. P., Sadler, J. J., Butter, L. M., Teske, G. J., Ulland, T. K., Eisenbarth, S. C., Florquin, S., Flavell, R. A., Leemans, J. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908698106 · Cited by 691 · see citing works
Zhou, Q., Wang, H., Schwartz, D. M., Stoffels, M., Park, Y. H., Zhang, Y., Yang, D., Demirkaya, E., Takeuchi, M., Tsai, W. L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3459 · Cited by 643 · see citing works
Hua, X., Yokoyama, C., Wu, J. I., Briggs, M. R., Brown, M. S., Goldstein, J. L., & Wang, X. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11603 · Cited by 626 · see citing works
Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100613 · Cited by 617 · see citing works
Lipid homeostasis, lipotoxicity and the metabolic syndrome
Unger, R. H., Clark, G. O., Scherer, P. E., & Orci, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.006 · Cited by 595 · see citing works
Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585 · see citing works
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
Zanoni, I., Tan, Y., Di Gioia, M., Broggi, A., Ruan, J., Shi, J., Donado, C. A., Shao, F., Wu, H., Springstead, J. R., et al. (2016) · Science · doi:10.1126/science.aaf3036 · Cited by 583 · see citing works
Franchi, L., Eigenbrod, T., & Núñez, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900173 · Cited by 574 · see citing works
Gurung, P., Anand, P., Malireddi, R. K. S., Walle, L. V., Opdenbosch, N. V., Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., & Kanneganti, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302839 · Cited by 558 · see citing works
Caspase-11 Protects Against Bacteria That Escape the Vacuole
Aachoui, Y., Leaf, I. A., Hagar, J. A., Fontana, M. F., Campos, C. G., Zak, D. E., Tan, M. H., Cotter, P. A., Vance, R. E., Aderem, A. A., et al. (2013) · Science · doi:10.1126/science.1230751 · Cited by 544 · see citing works
Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1
Broz, P., Ruby, T., Belhocine, K., Bouley, D. M., Kayagaki, N., Dixit, V. M., & Monack, D. M. (2012) · Nature · doi:10.1038/nature11419 · Cited by 535 · see citing works
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease
Holvoet, P., Mertens, A. C., Verhamme, P. B., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & de Werf, F. V. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530 · see citing works
The Membrane Attack Complex of Complement
Müller‐Eberhard, H. J. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.002443 · Cited by 507 · see citing works
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Walle, L., Opdenbosch, N. V., Jacques, P., Fossoul, A., Verheugen, E., Vogel, P., Beyaert, R., Elewaut, D., Kanneganti, T., van Loo, G., et al. (2014) · Nature · doi:10.1038/nature13322 · Cited by 499 · see citing works
Inflammasomes in liver diseases
Szabó, G., & Csák, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.035 · Cited by 498 · see citing works
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Wree, A., McGeough, M. D., Peña, C. A., Schlattjan, M., Li, H., Inzaugarat, M. E., Messer, K., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1170-1 · Cited by 486 · see citing works
NLRP3 inflammasome activity is negatively controlled by miR-223
Bauernfeind, F., Rieger, A., Schildberg, F. A., Knolle, P. A., Schmid-Burgk, J. L., & Hornung, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201516 · Cited by 463 · see citing works
Detection and localization of tumor necrosis factor in human atheroma
Barath, P., Fishbein, M. C., Cao, J., Berenson, J. R., Helfant, R. H., & Forrester, J. S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90291-8 · Cited by 448 · see citing works
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Frede, S., Stockmann, C., Freitag, P., & Fandrey, J. (2006) · Biochemical Journal · doi:10.1042/bj20051839 · Cited by 436 · see citing works
Bronner, D. N., Abuaita, B. H., Chen, X., Fitzgerald, K. A., Núñez, G., He, Y. O., Yin, X., & O’Riordan, M. X. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.008 · Cited by 434 · see citing works
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid
Bigoni, M., Turati, M., Gandolla, M., Sacerdote, P., Piatti, M., Castelnuovo, A., Franchi, S., Gorla, M., Munegato, D., Gaddi, D., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/8243601 · Cited by 431 · see citing works
Ribas, C., Penela, P., Murga, C., Salcedo, A., García‐Hoz, C., Jurado-Pueyo, M., Aymerich, I., & Mayor, F. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.019 · Cited by 409 · see citing works
ER stress induces NLRP3 inflammasome activation and hepatocyte death
Lebeaupin, C., Proïcs, E., de Bieville, C.-H. D., Rousseau, D., Bonnafous, S., Patouraux, S., Adam, G., Lavallard, V., Rovère, C., Thuc, O. L., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.248 · Cited by 400 · see citing works
MicroRNA therapeutics: Discovering novel targets and developing specific therapy
Christopher, A., Kaur, R., Kaur, G., Kaur, A., Gupta, V., & Bansal, P. (2016) · Perspectives in Clinical Research · doi:10.4103/2229-3485.179431 · Cited by 394 · see citing works
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects
Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 383 · see citing works
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Doyle, S., Ozaki, E., & Campbell, M. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s51250 · Cited by 382 · see citing works
Puren, A. J., Fantuzzi, G., & Dinarello, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2256 · Cited by 379 · see citing works
Baker, P. J., Boucher, D., Bierschenk, D., Tebartz, C., Whitney, P. G., D’Silva, D. B., Tanzer, M. C., Monteleone, M. M., Robertson, A. A. B., Cooper, M. A., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545655 · Cited by 370 · see citing works
Self-citationTriantafilou, K., Hughes, T. R., Triantafilou, M., & Morgan, B. P. (2013) · Journal of Cell Science · doi:10.1242/jcs.124388 · Cited by 361 · see citing works
Self-citationMolecular mechanisms involved in inflammasome activation
Bryant, C. E., & Fitzgerald, K. A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.06.002 · Cited by 351 · see citing works
Self-citationWilms, H., Sievers, J., Rickert, U., Rostami‐Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 346 · see citing works
Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K. M., Budelsky, A., & Wills-Karp, M. A. (2010) · Nature Immunology · doi:10.1038/ni.1926 · Cited by 329 · see citing works
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
Lagathu, C., Yvan‐Charvet, L., Bastard, J., Maachi, M., Quignard‐Boulangé, A., Capeau, J., & Caron, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0335-z · Cited by 323 · see citing works
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 319 · see citing works
Holvoet, P., Kritchevsky, S. B., Tracy, R. P., Mertens, A. C., Rubin, S. M., Butler, J., Goodpaster, B. H., & Harris, T. B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1068 · Cited by 318 · see citing works
IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes
Man, S. M., Karki, R., Sasai, M., Place, D. E., Kesavardhana, S., Temirov, J., Frase, S., Zhu, Q., Malireddi, R. K. S., Kuriakose, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.012 · Cited by 312 · see citing works
Asgari, E., Friec, G. L., Yamamoto, H., Perucha, E., Sacks, S. H., Köhl, J., Cook, H. T., & Kemper, C. (2013) · Blood · doi:10.1182/blood-2013-05-502229 · Cited by 311 · see citing works
Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release
Samstad, E. O., Niyonzima, N., Nymo, S. H., Aune, M. H., Ryan, L., Bakke, S. S., Lappegård, K. T., Brekke, O., Lambris, J. D., Damås, J. K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302484 · Cited by 286 · see citing works
Ichinohe, T., Yamazaki, T., Koshiba, T., & Yanagi, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312571110 · Cited by 284 · see citing works
Ito, A., Hong, C., Rong, X., Zhu, X., Tarling, E. J., Hedde, P. N., Gratton, E., Parks, J., & Tontonoz, P. (2015) · eLife · doi:10.7554/elife.08009 · Cited by 281 · cited 1× · see citing works
“Similarly, while the activation of LXRs reduces cholesterol and negatively regulates IL1Btranscription ([43]), activation of SREBPs not only increases cholesterol synthesis but also increases inflammasome priming, as shown in human umbilical vein endothelial cells (HUVEC) in vitro, and in mouse aortas in vivo([44]).”
Song, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273 · see citing works
Simard, J.-C., Césaro, A., Chapeton-Montes, J. A., Tardif, M. R., Antoine, F., Girard, D., & Tessier, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072138 · Cited by 263 · see citing works
Xiao, H., Lu, M., Lin, T. Y., Chen, Z., Chen, G., Wang, W.-C., Marin, T., Shentu, T.-P., Wen, L., Gongol, B., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002714 · Cited by 257 · see citing works
Pazár, B., Ea, H., Narayan, S., Kolly, L., Bagnoud, N., Chobaz, V., Roger, T., Lioté, F., So, A. K.-L., & Busso, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001284 · Cited by 252 · see citing works
Gurung, P., Malireddi, R. K. S., Anand, P., Demon, D., Walle, L. V., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401406 · Cited by 239 · see citing works
Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
Fernandes‐Alnemri, T., Kang, S., Anderson, C., Sagara, J., Fitzgerald, K. A., & Alnemri, E. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301681 · Cited by 235 · see citing works
Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments
Haneklaus, M., O'Neill, L. A. J., & Coll, R. C. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.004 · Cited by 230 · see citing works
Westwell-Roper, C. Y., Ehses, J. A., & Verchere, C. B. (2013) · Diabetes · doi:10.2337/db13-0863 · Cited by 225 · see citing works
The membrane attack complex as an inflammatory trigger
Morgan, B. P. (2016) · Immunobiology · doi:10.1016/j.imbio.2015.04.006 · Cited by 205 · see citing works
Couillard, C., Ruel, G., Archer, W., Pomerleau, S., Bergeron, J., Couture, P., Lamarche, B., & Bergeron, N. (2005) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2004-2438 · Cited by 204 · see citing works
Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function
Ghonime, M. G., Shamaa, O. R., Das, S., El-Domany, R. A., Fernandes‐Alnemri, T., Alnemri, E. S., Gavrilin, M. A., & Wewers, M. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301974 · Cited by 200 · see citing works
Cutting Edge: The NLRP3 Inflammasome Links Complement-Mediated Inflammation and IL-1β Release
Laudisi, F., Spreafico, R., Evrard, M., Hughes, T. R., Mandriani, B., Kandasamy, M., Morgan, B. P., Sivasankar, B., & Mortellaro, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300489 · Cited by 198 · see citing works
Peng, H., Guerau‐de‐Arellano, M., Mehta, V. B., Yang, Y., Huss, D. J., Papenfuss, T. L., Lovett‐Racke, A. E., & Racke, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383380 · Cited by 196 · see citing works
Robblee, M. M., Kim, C. C., Abate, J. P., Valdearcos, M., Sandlund, K. L. M., Shenoy, M. K., Volmer, R., Iwawaki, T., & Koliwad, S. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.053 · Cited by 193 · see citing works
C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.
Haeffner‐Cavaillon, N., Cavaillon, J., Laude, M., & Kazatchkine, M. D. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.3.794 · Cited by 177 · see citing works
Li, Y., Zhang, P., Wang, C., Han, C., Meng, J., Liu, X., Xu, S., Li, N., Wang, Q., Shi, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454538 · Cited by 177 · see citing works
Zheng, Q., Ren, Y., Reinach, P. S., Xiao, B., Lu, H., Zhu, Y., Qu, J., & Chen, W. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.02.013 · Cited by 175 · see citing works
Reynolds, C. M., McGillicuddy, F. C., Harford, K. A., Finucane, O. M., Mills, K. H. G., & Roche, H. M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200058 · Cited by 168 · see citing works
López‐Castejón, G., Luheshi, N., Compan, V., High, S., Whitehead, R. C., Flitsch, S. L., Kirov, A., Prudovsky, I. A., Swanton, E., & Brough, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422238 · Cited by 166 · see citing works
Deshaies, R. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1887 · Cited by 162 · see citing works
Schauvliege, R., Vanrobaeys, J., Schotte, P., & Beyaert, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207852200 · Cited by 162 · see citing works
Wang, W., Ding, X., Gu, T.-T., Song, L., Li, J., Xue, Q., & Kong, L. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.029 · Cited by 155 · see citing works
Holvoet, P., Jenny, N. S., Schreiner, P. J., Tracy, R. P., & Jacobs, D. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.002 · Cited by 149 · see citing works
Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity
Napier, B. A., Brubaker, S. W., Sweeney, T. E., Monette, P., Rothmeier, G. H., Gertsvolf, N. A., Puschnik, A., Carette, J. E., Khatri, P., & Monack, D. M. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160027 · Cited by 149 · see citing works
Gurung, P., Li, B., Malireddi, R. K. S., Lamkanfi, M., Geiger, T. L., & Kanneganti, T. (2015) · Scientific Reports · doi:10.1038/srep14488 · Cited by 147 · see citing works
Liu, X., Zhou, W., Zhang, X., Lü, P., Du, Q., Tao, L., Ding, Y., Wang, Y., & Hu, R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.002 · Cited by 146 · see citing works
Moderate Hypoxia Potentiates Interleukin-1β Production in Activated Human Macrophages
Folco, E. J. E., Sukhova, G. K., Quillard, T., & Libby, P. (2014) · Circulation Research · doi:10.1161/circresaha.115.304437 · Cited by 145 · see citing works
CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease
Kuemmerle-Deschner, J. B. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0491-7 · Cited by 143 · see citing works
RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Alexiou, P., Chatzopoulou, M., Pegklidou, K., & Demopoulos, V. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331086 · Cited by 138 · see citing works
Identification of a Locus on Chromosome 1q44 for Familial Cold Urticaria
Hoffman, H. M., Wright, F. A., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2000) · The American Journal of Human Genetics · doi:10.1086/302874 · Cited by 137 · see citing works
Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors
Jiang, H., Kuang, Y., Wu, Y., Smrcka, A. V., Simon, M. I., & Wu, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13430 · Cited by 137 · see citing works
Bauernfeind, F., Niepmann, S., Knolle, P. A., & Hornung, V. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501336 · Cited by 137 · see citing works
Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
Masters, S. L., & O'Neill, L. A. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.005 · Cited by 134 · see citing works
Self-citationDetection of immune danger signals by NALP3
Martinon, F. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607362 · Cited by 134 · see citing works
Frank, M. G., Weber, M. D., Fonken, L. K., Hershman, S. A., Watkins, L. R., & Maier, S. F. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.009 · Cited by 133 · see citing works
Bacterial recognition pathways that lead to inflammasome activation
Storek, K. M., & Monack, D. M. (2015) · Immunological Reviews · doi:10.1111/imr.12289 · Cited by 129 · see citing works
Crystal Formation in Inflammation
Franklin, B. S., Mangan, M., & Latz, E. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055539 · Cited by 125 · see citing works
Mapping of the C5a receptor signal transduction network in human neutrophils.
Buhl, A. M., Avdi, N. J., Worthen, G. S., & Johnson, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9190 · Cited by 123 · see citing works
Tobisawa, S., Hozumi, Y., Arawaka, S., Koyama, S., Wada, M., Nagai, M., Aoki, M., Itoyama, Y., Goto, K., & Kato, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00353-x · Cited by 122 · see citing works
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway
Perianayagam, M. C., Balakrishnan, V. S., King, A. J., Pereira, B. J. G., & Jaber, B. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00139.x · Cited by 121 · see citing works
Chen, S., Smith, B. A. H., Iype, J. M., Prestipino, A., Pfeifer, D., Grundmann, S., Schmitt-Graeff, A. H., Idzko, M., Beck, Y., Prinz, G., et al. (2015) · Blood · doi:10.1182/blood-2014-12-617258 · Cited by 107 · see citing works
la Sala, A., Gadina, M., & Kelsall, B. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2994 · Cited by 106 · see citing works
Nakamura, Y., Franchi, L., Kambe, N., Meng, G., Strober, W., & Núñez, G. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.013 · Cited by 104 · see citing works
Mullmann, T. J., Siegel, M. I., Egan, R. W., & Billah, M. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1901 · Cited by 99 · see citing works
Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes
Kim, Y., Wang, W., Okla, M., Kang, I., Moreau, R. F., & Chung, S. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m062828 · Cited by 98 · see citing works
Lupfer, C. R., Anand, P., Liu, Z., Stokes, K. L., Vogel, P., Lamkanfi, M., & Kanneganti, T. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004410 · Cited by 97 · see citing works
Negative regulation of NLRP3 inflammasome signaling
Chen, S., & Sun, B. (2013) · Protein & Cell · doi:10.1007/s13238-013-2128-8 · Cited by 83 · see citing works
Butyric acid in functional constipation
Pituch, A., Walkowiak, J., & Banaszkiewicz, A. (2013) · Gastroenterology Review · doi:10.5114/pg.2013.38731 · Cited by 78 · see citing works
MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2
Bandyopadhyay, S., Lane, T., Rajanbabu, V., Parthasarathy, P. T., Cho, Y., Galam, L., Lockey, R. F., & Kolliputi, N. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.056 · Cited by 77 · see citing works
Brandstetter, C., Holz, F. G., & Krohne, T. U. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671180 · Cited by 72 · see citing works
Complement C5a potentiates uric acid crystal‐induced IL‐1β production
An, L., Mehta, P., Xu, L., Turman, S., Reimer, T., Naiman, B. M., Connor, J. R., Sanjuán, M. A. F., Kolbeck, R., & Fung, M. S. C. (2014) · European Journal of Immunology · doi:10.1002/eji.201444560 · Cited by 71 · see citing works
Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation
Suresh, R., Chandrasekaran, P., Sutterwala, F. S., & Mosser, D. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.179291 · Cited by 68 · see citing works
Bezbradica, J. S., Coll, R. C., & Schroder, K. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.11 · Cited by 66 · see citing works
Ceramide triggers an NF-κB-dependent survival pathway through calpain
Demarchi, F., Bertoli, C., Greer, P. A., & Schneider, C. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401592 · Cited by 60 · see citing works
Autoinflammatory Skin Disorders: The Inflammasome in Focus
Gurung, P., & Kanneganti, T. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.003 · Cited by 55 · see citing works
Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation
Hwang, I., Lee, E., Jeon, S., & Yu, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.033 · Cited by 54 · see citing works
Westwell-Roper, C. Y., Denroche, H. C., Ehses, J. A., & Verchere, C. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712455 · Cited by 54 · see citing works
Haggadone, M. D., Grailer, J. J., Fattahi, F., Zetoune, F. S., & Ward, P. A. (2016) · Mediators of Inflammation · doi:10.1155/2016/1340156 · Cited by 50 · see citing works
Panchanathan, R., Liu, H., & Choubey, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8594 · Cited by 46 · see citing works
Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages
Filardy, A. A., He, J., Bennink, J. R., Yewdell, J. W., & Kelsall, B. L. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.109 · Cited by 45 · see citing works
Miljković, D. M., Blaževski, J., Petković, F., Djedović, N., Momčilović, M. B., Stanisavljević, S., Jevtić, B., Stojković, M. M., & Spasojević, I. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402302 · Cited by 44 · see citing works
Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation
Patel, M. N., Bernard, W. G., Milev, N. B., Cawthorn, W. P., Figg, N. L., Hart, D., Prieur, X., Virtue, S., Hegyi, K., Bonnafous, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414536112 · Cited by 42 · see citing works
Self-citationYstgaard, M. B., Sejersted, Y., Løberg, E. M., Lien, E., Yndestad, A., & Saugstad, O. D. (2015) · Neonatology · doi:10.1159/000437247 · Cited by 41 · see citing works
Lapointe, A., Couillard, C., Piché, M., Weisnagel, S. J., Bergeron, J., Nadeau, A., & Lemieux, S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.036 · Cited by 36 · see citing works
TANGI, T. N., Elmabsout, A. A., Bengtsson, T., Sirsjö, A., & Fransén, K. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1026 · Cited by 31 · see citing works
Ho, R. C., Davy, K. P., Davy, B. M., & Melby, C. L. (2002) · Metabolism · doi:10.1053/meta.2002.35577 · Cited by 30 · see citing works
Haas, B., Chrusciel, S., Fayad‐Kobeissi, S., Dubois‐Randé, J., Azuaje, F. J., Boczkowski, J., Motterlini, R., & Foresti, R. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24844 · Cited by 26 · see citing works
Kim, E., Won, J.-H., Hwang, I., & Yu, J. (2013) · Immune Network · doi:10.4110/in.2013.13.4.141 · Cited by 22 · see citing works
Fu, X., Ju, J., Lin, Z., Xiao, W., Li, X., Baoxiang, Z., Zhang, T., Ma, X., Li, X., Ma, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30239 · Cited by 22 · see citing works
Suppression of caspase-11 expression by histone deacetylase inhibitors
Heo, H., Yoo, L., Shin, K. S., & Kang, S. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.009 · Cited by 10 · see citing works
Inflammasome Activation: How Macrophages Watch What They Eat
Vance, R. E. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2009.12.011 · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- J. Exp. Med., 213 (2016), pp. 2365 -2382
Cited by
Sorted by citations
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 629 · see citing works
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 418 · see citing works
Han, X., Sun, S., Sun, Y., Song, Q., Zhu, J., Song, N., Chen, M., Sun, T., Xia, M., Ding, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596481 · Cited by 408 · see citing works
Zhang, Y., Liu, X., Bai, X., Yuan, L., Li, Z., Fu, J., Li, M., Zhao, T., Yang, H., Xu, R., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12449 · Cited by 395 · see citing works
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387 · see citing works
LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
Wan, P., Su, W., Zhang, Y., Li, Z., Deng, C., Li, J., Jiang, N., Huang, S., Long, E., & Zhuo, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0351-4 · Cited by 292 · see citing works
Inflammasomes in Tissue Damages and Immune Disorders After Trauma
Bortolotti, P., Faure, E., & Kipnis, É. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01900 · Cited by 259 · see citing works
Wooff, Y., Man, S. M., Aggio‐Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 244 · see citing works
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Deora, V., Lee, J. D., Albornoz, E. A., McAlary, L., Jagaraj, C. J., Robertson, A. A. B., Atkin, J. D., Cooper, M. A., Schroder, K., Yerbury, J. J., et al. (2020) · Glia · doi:10.1002/glia.23728 · Cited by 245 · see citing works
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
McKee, C. M., & Coll, R. C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-513r · Cited by 236 · see citing works
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Hamarsheh, S., & Zeiser, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01444 · Cited by 227 · see citing works
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
O’Brien, W. T., Pham, L., Symons, G. F., Monif, M., Shultz, S. R., & McDonald, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01778-5 · Cited by 231 · see citing works
Microglia and CNS Interleukin-1: Beyond Immunological Concepts
Liu, X., & Quan, N. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00008 · Cited by 214 · see citing works
The role of inflammasomes in vascular cognitive impairment
Poh, L., Sim, W. L., Jo, D., Dinh, Q. N., Drummond, G. R., Sobey, C. G., Chen, C., Lai, M. K. P., Fann, D. Y., & Arumugam, T. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00506-8 · Cited by 167 · see citing works
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174 · see citing works
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Gritsenko, A., Yu, S., Martín‐Sánchez, F., Diaz-del-Olmo, I., Nichols, E.-M., Davis, D. M., Brough, D., & López‐Castejón, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565924 · Cited by 156 · see citing works
The P2X7 Receptor Primes IL-1β and the NLRP3 Inflammasome in Astrocytes Exposed to Mechanical Strain
Albalawi, F., Lu, W., Beckel, J. M., Lim, J. C., McCaughey, S. A., & Mitchell, C. H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00227 · Cited by 155 · see citing works
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 143 · see citing works
IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network
Schmacke, N. A., O’Duill, F., Gaidt, M. M., Szymanska, I., Kamper, J. M., Schmid-Burgk, J. L., Mädler, S. C., Mackens‐Kiani, T., Kozaki, T., Chauhan, D., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.021 · Cited by 138 · see citing works
Sand, J., Haertel, E., Biedermann, T., Contassot, E., Ernst Reichmann, A., French, L. E., Werner, S., & Beer, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0009-4 · Cited by 130 · see citing works
Gasdermin D mediates the maturation and release of IL-1α downstream of inflammasomes
Tsuchiya, K., Hosojima, S., Hara, H., Kushiyama, H., Mahib, M. R., Kinoshita, T., & Suda, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108887 · Cited by 135 · see citing works
Zhang, Q., Sun, J., Wang, Y., He, W., Wang, L., Zheng, Y., Wu, J., Zhang, Y., & Jiang, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02142 · Cited by 123 · see citing works
Interaction between autophagy and the NLRP3 inflammasome
Cao, Z., Wang, Y., Long, Z., & He, G. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz098 · Cited by 119 · see citing works
The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Ratajczak, M. Z., Bujko, K., Cymer, M., Thapa, A., Adamiak, M., Ratajczak, J., Abdel-Latif, A. K., & Kucia, M. (2020) · Leukemia · doi:10.1038/s41375-020-0827-8 · Cited by 102 · see citing works
Yang, M.-Y., Lv, H., Liu, Q., Zhang, L., Zhang, R.-X., Huang, X.-T., Wang, X.-D., Han, B., Hou, S., Liu, D.-D., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9173530 · Cited by 87 · see citing works
Jiang, Y., Liu, H., Yu, H., Zhou, Y., Zhang, J., Xin, W., Li, Y., He, S., Ma, C., Zheng, X., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315525 · Cited by 101 · see citing works
Deng, X., Huang, W., Peng, J., Zhu, T., Sun, X.-L., Zhou, X.-Y., Yang, H., Xiong, J., He, H.-Q., Xu, Y.-H., et al. (2017) · Inflammation · doi:10.1007/s10753-017-0685-3 · Cited by 92 · see citing works
Inflammasome activation and Th17 responses
Deng, J. P., Yu, X., & Wang, P. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 94 · see citing works
The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
Jiang, D., Chen, S., Sun, R., Zhang, X., & Wang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.034 · Cited by 94 · see citing works
Stødle, G. S., da Silva, G. B., Tangerås, L. H., Gierman, L. M., Nervik, I., Dahlberg, U. E., Sun, C., Aune, M. H., Thomsen, L. C. V., Bjørge, L., et al. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13130 · Cited by 93 · see citing works
Circulating mitochondria in organ donors promote allograft rejection
Lin, L., Xu, H., Bishawi, M. M., Feng, F., Samy, K. P., Truskey, G. A., Barbas, A. S., Kirk, A. D., & Brennan, T. V. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15309 · Cited by 89 · see citing works
Lipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis
Gibson, M. S., Domingues, N. S., & Vieira, O. V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00654 · Cited by 86 · see citing works
Pirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 83 · see citing works
Zhao, P., Yin, S., Qiu, Y., Sun, C., & Yu, H. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02217-2 · Cited by 90 · see citing works
Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 82 · see citing works
Eren, E., Tüfekçi, K. U., Isci, K. B., Tastan, B., Genç, K., & Genç, Ş. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00036 · Cited by 84 · see citing works
Kovács, Z., D’Agostino, D. P., Diamond, D. M., Kindy, M. S., Rogers, C. Q., & Ari, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00363 · Cited by 84 · see citing works
Pan, H., Lin, Y., Dou, J., Fu, Z. F., Yao, Y., Ye, S., Zhang, S., Wang, N., Liu, A., Li, X., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12868 · Cited by 80 · see citing works
Oseni, S. O., Naar, C., Pavlović, M. D., Asghar, W., Hartmann, J. X., Fields, G. B., Esiobu, N., & Kumi-Diaka, J. K. (2023) · Cancers · doi:10.3390/cancers15123110 · Cited by 94 · see citing works
Rajan, T. S., Giacoppo, S., Diomede, F., Bramanti, P., Trubiani, O., & Mazzon, E. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017722332 · Cited by 79 · see citing works
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 74 · see citing works
The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury
Xu, K., Wu, C., Tong, S., Peng, X., & Wang, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.089 · Cited by 73 · see citing works
Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
Takahashi, M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000709 · Cited by 76 · see citing works
Hadri, K. E., Smith, R., Duplus, E., & Amri, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010077 · Cited by 70 · see citing works
Frame, J. M., Kubaczka, C., Long, T. L., Esain, V., Soto, R. A., Hachimi, M., Jing, R., Shwartz, A., Goessling, W., Daley, G. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.015 · Cited by 67 · see citing works
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 67 · see citing works
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 66 · see citing works
Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?
Wallert, M., Börmel, L., & Lorkowski, S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000097 · Cited by 66 · see citing works
Wang, Z., Zhang, A., Meng, W., Wang, T., Li, D., Liu, Z., & Liu, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.059 · Cited by 61 · see citing works
Zhu, J., Chen, H., Le, Y., Guo, J., Liu, Z., Dou, X., & Lu, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009229 · Cited by 61 · see citing works
Wang, X., Chi, J., Huang, D., Ding, L., Zhao, X., Jiang, L., Yu, Y., & Gao, F. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8297 · Cited by 60 · see citing works
NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction
Sokolova, M., Sahraoui, A., Høyem, M., Øgaard, J., Lien, E., Aukrust, P., Yndestad, A., Ranheim, T., & Scholz, H. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00461.2017 · Cited by 60 · see citing works
Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
Wen, J., Chang, Y., Huo, S., Li, W., Huang, H., Gao, Y., Lin, H., Zhang, J., Zhang, Y., Zuo, Y., et al. (2020) · Aging · doi:10.18632/aging.202202 · Cited by 60 · see citing works
Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
Yu, Q., Zhao, T., Liu, M., Cao, D., Li, J., Li, Y., Xia, M., Wang, X., Zheng, T., Liu, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707696 · Cited by 59 · see citing works
Alves, J. V., da Costa, R. M., Pereira, C. A., Fedoce, A. G., Silva, C. A. A., Carneiro, F. S., Lobato, N. S., & Tostes, R. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01647 · Cited by 58 · see citing works
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
Alatshan, A., & Benkő, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630569 · Cited by 57 · see citing works
Alcohol accumulation promotes esophagitis via pyroptosis activation
Wang, F., Li, G., Ning, J., Chen, L., Xu, H., Kong, X., Bu, J., Zhao, W., Li, Z., Wang, X., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24347 · Cited by 54 · see citing works
Role of Perinatal Inflammation in Neonatal Arterial Ischemic Stroke
Giraud, A., Guiraut, C., Chevin, M., Chabrier, S., & Sébire, G. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00612 · Cited by 54 · see citing works
Jan, S. L., Muller, C. B., Plée, J., Durlach, A., Bernard, P., & Antonicelli, F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01972 · Cited by 53 · see citing works
Type I IFN drives unconventional IL-1β secretion in lupus monocytes
Caielli, S., Balasubramanian, P., Rodríguez-Alcázar, J. F., Balaji, U., Robinson, L. A., Wan, Z., Baisch, J. M., Smitherman, C., Walters, L., Sparagana, P. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.004 · Cited by 53 · see citing works
TNF- α potentiates uric acid-induced interleukin-1 β (IL-1 β ) secretion in human neutrophils
Yokose, K., Sato, S., Asano, T., Yashiro, M., Kobayashi, H., Watanabe, H., Suzuki, E., Sato, C., Kozuru, H., Yatsuhashi, H., et al. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1369924 · Cited by 54 · see citing works
Wu, H., Liu, X., Gao, Z., Lin, M. S., Zhao, X. S., Sun, Y. X., & Pu, X. (2021) · Antioxidants · doi:10.3390/antiox10040529 · Cited by 53 · see citing works
NLRP3 Inflammasome Participates in Host Response to Neospora caninum Infection
Wang, X., Gong, P., Zhang, X., Li, S., Lu, X.-Y., Zhao, C., Yu, Q., Wei, Z., Yang, Y., Liu, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01791 · Cited by 51 · see citing works
Jin, J., Lv, X., Wang, B., Ren, C., Jiang, J., Chen, H., Chen, X., Gu, M., Pan, Z., Tian, N., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7292512 · Cited by 50 · see citing works
COPs and POPs Patrol Inflammasome Activation
Indramohan, M., Stehlik, C., & Dorfleutner, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.004 · Cited by 48 · see citing works
Wang, Y., Sui, Z., Wang, M., & Liu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196016 · Cited by 47 · see citing works
Botto, S., Abraham, J., Mizuno, N., Pryke, K. M., Gall, B., Landais, I., Streblow, D. N., Früh, K., & DeFilippis, V. R. (2019) · mBio · doi:10.1128/mbio.02510-18 · Cited by 48 · see citing works
D’Espessailles, A., Mora, Y. A., Fuentes, C., & Cifuentes, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26490 · Cited by 46 · see citing works
Ye, A., Li, W., Zhou, L., Ao, L., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.009 · Cited by 46 · see citing works
Triantafilou, K., Ward, C. J. K., Czubala, M. A., Ferris, R. G., Koppe, E. L., Haffner, C. D., Piguet, V., Patel, V. K., Amrine‐Madsen, H., Modis, L. K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009417 · Cited by 45 · see citing works
Self-citationNLRP3 in somatic non-immune cells of rodent and primate testes
Walenta, L., Schmid, N., Schwarzer, J., Köhn, F., Urbanski, H. F., Behr, R., Strauss, L., POUTANEN, M. H., & Mayerhofer, A. (2018) · Reproduction · doi:10.1530/rep-18-0111 · Cited by 45 · see citing works
Rahman, K., & Fisher, E. A. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00032 · Cited by 44 · see citing works
Effects of phosphorylation on the NLRP3 inflammasome
Sandall, C. F., & MacDonald, J. A. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.020 · Cited by 44 · see citing works
Zhang, L., Lu, L., Zhong, X., Yue, Y., Hong, Y., Li, Y., & Li, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.006 · Cited by 44 · see citing works
Sousa, C., Leitão, A. J., Neves, B. M., Judas, F., Cavaleiro, C., & Mendes, A. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-64032-1 · Cited by 43 · see citing works
Zhou, P., Dai, J., Zhang, K., Wang, T., Li, L., Luo, Y., Sun, Y., Qiu, H., & Li, S. (2022) · Journal of Virology · doi:10.1128/jvi.00954-22 · Cited by 43 · see citing works
Jia, K., Ding, H., Yu, H., Dong, T., Pan, Y., & Kong, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/3093516 · Cited by 43 · see citing works
NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
Sokolova, M., Sjaastad, I., Louwe, M. C., Alfsnes, K., Aronsen, J. M., Zhang, L., Haugstad, S. B., Bendiksen, B. A., Øgaard, J., Bliksøen, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01621 · Cited by 42 · see citing works
Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome
Pizzuto, M., Pelegrı́n, P., & Ruysschaert, J. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101182 · Cited by 41 · see citing works
Atherosclerosis and Its Related Laboratory Biomarkers
Corte, V. D., Todaro, F., Cataldi, M., & Tuttolomondo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115546 · Cited by 41 · see citing works
Bao, J., Sun, T., Yue, Y., & Xiong, S. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.012 · Cited by 41 · see citing works
Sokolova, M., Yang, K., Hansen, S. H., Louwe, M. C., Kummen, M., Hov, J. R., Sjaastad, I., Berge, R. K., Halvorsen, B. L., Aukrust, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76497-1 · Cited by 40 · see citing works
Zhou, L., Huang, W. G., Xu, Y., Gao, C., Zhang, T., Guo, M., Liu, Y., Ding, J., Qin, L., Xu, Z., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7078214 · Cited by 38 · see citing works
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
Bertinaria, M., Gastaldi, S., Marini, E., & Giorgis, M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.013 · Cited by 37 · see citing works
Sartoretto, S. C., Piperni, S. G., da Silva, R. A., Calasans‐Maia, M. D., Rucci, N., dos Santos, T. M. P., Lima, I., Rossi, A. M., Alves, G. G., Granjeiro, J. M., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27226 · Cited by 35 · see citing works
The NLRP1 inflammasome in skin diseases
Burian, M., Schmidt, M. F., & Yazdi, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111611 · Cited by 34 · see citing works
Podocyte NADPH Oxidase 5 Promotes Renal Inflammation Regulated by the Toll-Like Receptor Pathway
Holterman, C. E., Boisvert, N. C., Thibodeau, J.-F., Kamto, E., Novakovic, M., Abd‐Elrahman, K. S., Ferguson, S. S. G., & Kennedy, C. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7402 · Cited by 34 · see citing works
Öörni, K., & Kovanen, P. T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081769 · Cited by 34 · see citing works
Diaz-del-Olmo, I., Worboys, J. D., Martín‐Sánchez, F., Gritsenko, A., Ambrose, A. R., Tannahill, G. M., Nichols, E.-M., López‐Castejón, G., & Davis, D. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720655 · Cited by 35 · see citing works
Sun, L., Yuan, H., & Zhao, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-22617-y · Cited by 32 · see citing works
He, X., Li, C., Yin, H., Tan, X., Yi, J., Tian, S., Wang, Y., & Liu, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2052652 · Cited by 33 · see citing works
Ferko, M.-A., & Catelas, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199936 · Cited by 33 · see citing works
Xu, K., Tong, S., Wu, C., Ding, X., Chen, J.-L., Yu, M., & Wang, S. (2020) · Transplantation · doi:10.1097/tp.0000000000003208 · Cited by 33 · see citing works
Li, L., Wang, X., Gong, P., Zhang, N., Zhang, X., Li, S., Li, X., Liu, S.-X., Zhang, X.-X., Li, W., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04331-8 · Cited by 33 · see citing works
Fenini, G., Karakaya, T., Hennig, P., Filippo, M. D., Slaufova, M., & Beer, H. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.04.004 · Cited by 33 · see citing works
Inflammasome activation by Gram-positive bacteria: Mechanisms of activation and regulation
Keestra-Gounder, A. M., & Nagao, P. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1075834 · Cited by 31 · see citing works
Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy
Fan, Y., Guan, B., Xu, J., Zhang, H., Liang, Y., & Yang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115493 · Cited by 34 · see citing works
Sun, Y. J., Huang, W.-M., Tang, P.-C., Zhang, X., Zhang, X.-Y., Yu, B.-C., Fan, Y. M., Ge, X., & Zhang, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104274 · Cited by 33 · see citing works
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Thapa, P., Upadhyay, S. P., Singh, V., Boinpelly, V. C., Zhou, J., Johnson, D. K., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100100 · Cited by 32 · see citing works
- Authors
- Patel, M. N., Carroll, R. G., Galván-Peña, S., Mills, E. L., Olden, R., Triantafilou, M., Wolf, A. I., Bryant, C. E., Triantafilou, K., & Masters, S. L.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- GlaxoSmithKline (United States) (US)
- The University of Melbourne (AU)
- Corresponding author
- Masters, Seth L.
- ORCID
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 23
- Issue
- 2
- Pages
- 165-180
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2572287198
- Cited by
- 241
- References
- 153
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 15 · 2023: 24 · 2022: 29 · 2021: 25 · 2020: 37 · 2019: 31 · 2018: 33 · 2017: 17 · 2015: 1
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- inflammasome priming, sterile inflammation, NLRP3 inflammasome, caspase-11, IL-1β processing, IL-18, pyroptosis, post-translational modification, atherosclerosis, metabolic disorders, neuroinflammation, Toll-like receptor ligands
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Animals, Humans, Immunity, Innate, Inflammation, Metabolic Diseases, Obesity, Neuroimmunomodulation, Atherosclerosis, Toll-Like Receptors, Interleukin-1beta, Hereditary Autoinflammatory Diseases, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review